+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2 percent cyclosporine



Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2 percent cyclosporine



Veterinary Immunology & Immunopathology 49(3): 199-208



Peripheral cellular immunity of ten dogs with keratoconjunctivitis sicca (KCS) that had not been treated with topical corticosteroids or cyclosporine was evaluated (by use of in vitro lymphocyte proliferation assays and CD4+/CD8+ lymphocyte subset analysis) before and after 1 and 3 months of treatment with topical ocular 2% cyclosporine (CsA). In vitro lymphocyte proliferation and CD4+/CD8+ lymphocyte subset analysis was done in eight normal dogs at the 0, 1 and 3 month time periods to use for comparison. There was no significant difference in lymphocyte proliferation or numbers of CD4+ or CD8+ lymphocytes in dogs with KCS and normal dogs prior to CsA treatment. However, by 1 month's time, lymphocyte proliferation had decreased in the CsA-treated Dogs with KCS, and by 3 months there was a significant difference (P lt 0.0001) from the normal dogs. These results suggest that dogs with KCS may not have altered peripheral cellular immunity and that use of topical 2% cyclosporine for treatment of KCS causes a suppression of lymphocyte proliferation after 1 to 3 months of use.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008275686

Download citation: RISBibTeXText


Related references

Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine. Veterinary Immunology and Immunopathology 49(3): 199-208, 1995

Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca. American Journal of Veterinary Research 63(5): 688-694, 2002

Keratoconjunctivitis sicca in dogs: Treatment with topical cyclosporine. Veterinary medicine reportng 2(2): 115-127, 1990

Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs. Journal of the American Veterinary Medical Association 199(8): 1043-1046, 1991

Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs. Journal of the American Veterinary Medical Association 199(8): 1039-1042, 1991

Topical administration of petrolatum based cyclosporine for treatment of keratoconjunctivitis sicca in dogs. Journal of Veterinary Clinics 19(2): 260-263, 2002

Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine. Advances in Experimental Medicine and Biology 438: 997-1000, 1998

Microorganisms isolated from the corneal surface before and during topical cyclosporine treatment in dogs with keratoconjunctivitis sicca. American Journal of Veterinary Research 56(7): 880-884, 1995

Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine. Biotechnic and Histochemistry 90(3): 223-230, 2015

Topical cyclosporine therapy for keratoconjunctivitis sicca in dogs. Cornell Veterinarian 79(3): 207-209, 1989

Topical application of cyclosporine in the management of keratoconjunctivitis sicca in dogs. Journal of the American Animal Hospital Association 26(3): 269-274, 1990

Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca. Klinische Monatsblatter für Augenheilkunde 229(5): 548-553, 2012

Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. Archives of Ophthalmology 107(8): 1210-1216, 1989

Lymphocyte proliferation and blood drug levels in dogs with keratoconjunctivitis sicca receiving long-term topical ocular cyclosporine. Veterinary & Comparative Ophthalmology 6(2): 125-130, 1996

Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group. American Journal of Ophthalmology 114(4): 441-447, 1992